Patient reporting of suspected adverse drug reactions (ADRs) has the potential to add value to pharmacovigilance by:
- Addressing ADR under-reporting
- Identifying different types of drugs and reactions to those reported by healthcare professionals (HCPs)
- Generating potential new signals, and
- Describing suspected ADRs in enough detail to provide useful information on likely causality and impact on patients’ lives.
But patients, like HCPs, will only report ADRs if it is convenient and easy to do, and evidence suggests that the current methods are neither of these.
In contrast, smartphones are the ultimate convenience tool: always on, always with you, and network-connected much of the time. When combined with a well designed, easy-to-use and validated app they offer the potential to significantly improve spontaneous ADR reporting.
Virtual PV will shortly complete development of a validated adverse event reporting app that can be used by patients, sales reps and HCPs. More details can be found here.